
Psychological Treatment for Sleepwalking: two case reports
2011; Elsevier BV; Volume: 66; Issue: 3 Linguagem: Inglês
10.1590/s1807-59322011000300028
ISSN1980-5322
AutoresSilvia G. Conway, Laura Castro, Maria Cecília Lopes-Conceição, Helena Hachul, Sérgio Tufik,
Tópico(s)Obstructive Sleep Apnea Research
ResumoSleep architecture and polysomnographic findings show that the majority of sleepwalking episodes occur during slow-wave sleep (SWS).1–4 Although genetics play an important role in the manifestation of sleepwalking,5,6 recent studies have shown that parasomnias are also associated with other sleep or mental disorders3,7,10,11 and psychological factors.3,7,10–14 Sleepwalking prevalence rates are higher in childhood15 than in adulthood.10 Due to the risk of injuries3,4,10,16,17 beyond the presence of associated symptoms,4,8 those who suffer from sleepwalking often seek medical treatment. Treatment is commonly based on pharmacologic intervention,18–20 particularly the use of the benzodiazepinic drug clonazepam.4,19,20 However, some patients do not respond to this medication19 or present side effects.21 The aim of this report was to demonstrate psychological integrity and functioning as a correlate of a sleepwalking predisposition and to describe a sleep disorder-focused psychotherapy as an option for treating sleepwalking in adults that shows effects on sleep-related behaviors, psychological symptoms, and objective sleep data.
Referência(s)